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Figure: Boxplot of the bladder volumes for each patient 
In the five lipiodol patients we found that the COM of the 
lipiodol depended on the bladder volume and the location of 
the lipiodol in the bladder. Based on this correlation we 
developed a model to predict the position of the lipiodol 
using the bladder volume. We calculated a margin based on 
the actual position of the lipiodol, and subsequently we 
calculated a margin based on the difference between the 
actual and the predicted position, Table. 
 
 
 
Conclusion: As confirmed in the literature the full bladder 
protocol does not result in a stable bladder filling, and the 
displacement in cranial-anterior direction was the largest. 
Taking the predicted location of the tumour volume into 
account in preparing the treatment plans of the day, a 
considerable reduction in margin is achieved. Therefore, we 
need daily on-line adaptive treatment to adequately treat 
the bladder. 
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Purpose or Objective: To evaluate interfraction volume 
changes and dose variations of organs at risk (OAR) and to 
develop individualized radiotherapy (iRT) concepts with 
movement compensation. This work analyzes the potential 
benefit of adaptive planning in patients with prostate 
carcinoma. 
 
Material and Methods: We analyzed 16 patients with 
prostate cancer treated with helical IMRT and daily image 
guidance. Eight patients received radiation after 
prostatectomy with a total dose of 68 Gy in 34 fractions 
(group A), and eight a definitive irradiation with a total dose 
of 76.5 Gy in 34 fractions (group B). OAR rectum and bladder 
were delineated on daily Megavoltage (MV)CTs With the 
Planned Adaptive software by Tomotherapy® (Accuray Inc., 
Sunnyvale, CA) we performed dose recalculations on the 
single fractions CTs and compared the summation dose with 
the original planned dose. Dose variations were analyzed by 
means of Dmedian, Dmean, Dmax, Dmin, V30, V40, V60, V70, 
V75, as well as the OAR volume. 
 
Results: Our evaluation is still ongoing. During treatment, 
rectum volume ranged from 62-223% (A: 62-157%, B: 63-223%) 
of its initial volume; bladder from 22-375% (A: 30-311%, B: 
22-375%). The mean of the Dmean in the rectum was 30.7 Gy 
and 37.2 Gy in group A and B, respectively; and for the 
bladder 26.4 Gy and 40.8 Gy. The dose statistics for the 
rectum was as follows: V30 22.2-90.2%, V40 14.2-80.5%, V60 
0.1-46.9%, only for group A: V70 1.0-22.3% and V75 0-7.2%. 
The statistics for the bladder are: V30 15.6-100.0%, V40 10.9-
100.0%, V60 3.8-89.8%, only for group A: V70 1.6-28.0%, V75 
0.5-19.4%. 
 
Conclusion: For patients with prostate cancer, relevant 
variations in volume of OAR, such as rectum and bladder, can 
be observed. Hence, corresponding dose variations occur. 
Adaptive replanning approaches have the potential to reduce 
the dose to OAR. However, which concept, e.g. “plan of the 
day” or fast online recalculation, will be the suitable solution 
for routine patient treatment needs to be assessed in further 
evaluations. 
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Purpose or Objective: To assess outcomes of patients with 
anal canal cancer treated with Intensity-Modulated Radiation 
Therapy (IMRT) after a long time follow-up. 
 
Material and Methods: From July 2007 to September 2015, 
233 patients were treated by IMRT for anal squamous cell 
carcinoma. In 2009, Volumetric Modulated Arc Therapy 
RapidArc (VMAT RA) rapidly became our usual way of 
radiation for this cancer. Radiotherapy consisted in delivering 
45 Gy in 1.8 Gy daily-fractions, 5 days a week, to the primary 
tumor and the risk area including pelvic and inguinal nodes 
(PTV1). A second plan of 14.4-20 Gy was administered to the 
primary tumor (PTV2) in 1.8-2 Gy daily-fractions, also 5 days 
a week (Image 1), or by pulsed-dose rate interstitial 
brachytherapy for some T1 and T2. PTV1 and PTV2 were 
treated continuously without gap and without Simultaneously 
Integrated Boost (SIB). Concurrent chemotherapy based on 
5FU-mitomycin (MMC) or cisplatin was added for locally 
advanced tumors. Toxicities were evaluated according to the 
Common Toxicity Criteria for Adverse Events 4.0 scale. The 
survival estimates and their associated CI95% were calculated 
using the Kaplan-Meier method. We present here the first 166 
patients’ outcomes. 
 
 
 
Results: Median follow-up was 46,7 months CI95% [41,2-
51,6]. 124 women (75%) and 42 men (25%) were analysed. 
Median age was 61 years (range, 36-92). Tumors were 
classified as stages I, II, III and IV in 13%, 25%, 57% and 4% of 
the cohort, respectively. 13 patients were 
immunocompromised, 10 of those were HIV-positive (6%). 
Radiochemotherapy (RCT) or radiotherapy alone (RT) was 
delivered in 132 (80%) and 34 (20%) patients, respectively: 
104 (79%) MMC, 25 (19%) cisplatin and 3 (2%) other regimens. 
21 patients (13%) had the PTV2 treated by brachytherapy. 
162 patients (97,6%) were complete responders. 36 patients 
(21.7%) had a relapse : 20 local (56%) among which were 3 
synchronous metastatic failures, 4 locoregional (11%) and 12 
metastatic without any local failure (33%). 33 patients (20%) 
had a colostomy following radiotherapy : 17 (46%) for local 
relapse, 12 (32%) for radiation toxicity, 3 (8%) for an 
uncomplete response, 1 (2,7%) for tumor complications 
during RCT. Concerning late toxicities: no grade 4 was 
observed; grade 3 were diarrhea (1 patient), proctitis (11), 
vaginal stricture (5), hematuria (1), fecal incontinence (4), 
chronic radiodermatitis (2 patients); 28 cases of grade 2 
occurred among those clinical categories. About the 
hematologic late toxicity, there wasn’t any significative 
difference between the blood count prior to treatment and 
the recent one (p=0.23). The 3-year overall survival rate was 
85.5% CI95% [78.7-90.3], cancer-specific survival 89,0% CI95% 
[82,5-93,1], disease-free survival 74.6% CI95% [67-80.8], 
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relapse-free survival 79.6 % CI95% [72.1-85.2] and colostomy-
free survival 81.2% CI95% [74.0-86.6]. 
 
Conclusion: IMRT is emerging as a standard therapy for anal 
cancer. A dosimetric analysis will be done to complete this 
study. 
 
Poster: RTT track: Other topics for RTTs  
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Purpose or Objective: The aim of the study was to explore 
the prostate patients’ perceptions of Virtual Environment for 
Radiotherapy Training (VERT) as an information giving 
resource prior to radiotherapy delivery.  
The objectives were:  
• To determine the level of knowledge of those patients who 
attended (VERT) for a pre-treatment talk  
• To explore patients perceptions who utilised (VERT) as an 
information giving resource prior to radiotherapy treatment 
• To identify the benefits and limitations of using VERT as 
pre-treatment information giving resource 
 
Material and Methods: A survey design was utilised to 
address the aims and objective of the study. The study was 
conducted over 2 phases: Phase 1 - participants were invited 
to attend a (VERT)patient information session four weeks 
prior to their planning CT scan. Phase 2 – patients were asked 
to complete a questionnaire two weeks after start of 
radiotherapy treatment. The questionnaire was designed to 
collect data on the prostate cancer patient’s knowledge 
attitudes and beliefs regarding pre-treatment information 
provided prior to their radiotherapy treatment. A total 
population sample was used for this study. All patients being 
referred for radical radiotherapy to the prostate were invited 
to participate, over a five month data collection period 
(March – August 2015). A total of n=40 patients were included 
in the sample 
 
Results: Statistical package SPSS (Version 21) was used for 
data analysis. Descriptive statistics and frequency tables 
were the first steps in the data analysis. Thereafter, Chi-
squared tests were used to analyse the data further. Open 
ended questions were analysed thematically. 
Results are currently being analysed however preliminary 
results are very positive, a summary of the preliminary 
results are outlined below (the final presentation will include 
frequency tables): 
•Most patients found the (VERT) session to be very helpful  
•Most patients stated that the session helped them to 
understand the importance of following bowel and bladder 
instructions prior to treatment and enhanced their knowledge 
about radiotherapy side effects 
•The sessions were highly recommended for other patients 
and future recommendations included family members and 
carers to be included. 
•Most patients were comfortable being part of a group during 
the presentation. 
•Patients believed the sessions reduced their anxiety and 
stress about their upcoming treatment. 
 
Conclusion: Patient perceptions on the use of (VERT) as 
information giving tool prior to radiotherapy treatment were 
very positive. The sessions enable patients to understand the 
potential impact of treatment volumes if the internal organ 
shape and location differed from that originally planned, 
enabling them to comply with radiotherapy treatment 
instructions. 
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Purpose or Objective:  
Aim: The question posed is “Can simulation training 
improve/enhance student knowledge and skills in dealing 
with bariatric patients?” 
Context: Accurate patient positioning, immobilisation and 
the delivery of precisely targeted radiation treatment are key 
stages in the radiotherapy process and bariatric patients 
present a unique challenge in achieving these stages. 
Radiotherapy for obese patients is a major challenge, both 
for the patient and the radiographer. There are practical 
limitations of radiation therapy equipment such as treatment 
couch weight limits and computed tomography (CT) scan 
aperture limits. Daily setup potentially is difficult. In 
addition, it also impacts on the safe manual handling on both 
staff and this group of patients. 
 
Material and Methods: As part of their professional practice 
clinical skills sessions, the Year one undergraduate 
radiotherapy students (n=32) took part in a simulation session 
involving a bariatric suit. During each session, the 
radiotherapy lecturer wore the bariatric suit whilst the 
students working in pairs were required to position the 
lecturer (acting as the patient) on the couch.  
After each simulation session, students were asked to 
complete a 10 point Likert scale questionnaire which 
permitted them to rate their experience of using the 
bariatric suit. A response rate of 100% was achieved.  
They were asked to consider the following 3 areas:  
•Whether it aided their learning in positioning patients’  
•Whether it increased their awareness to deal with different 
patient groups  
•Whether it increased their knowledge on the importance of 
accuracy and precision 
In addition, they were asked to write a short reflection to 
identify what they learnt from the session. 
 
Results: Students gave favourable feedback in all 3 areas 
investigated with a mean score above 4.5 (range -5 to +5) 
The written reflective feedback supported the above 
quantitative scores by acknowledging the benefits of 
simulated training 
 
Conclusion: The feedback from the students suggests that 
simulation training using a bariatric suit has had a positive 
impact on their learning. In addition, the sessions have 
assisted them in appreciating aspects as such as accuracy, 
precision, communication and manual handling issues. Most 
significantly students have acknowledged that the sessions 
have prepared them for their clinical placements. 
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Purpose or Objective: Image-guided radiation therapy (IGRT) 
utilises various imaging modalities for target and organs at 
risk delineation, tumour localisation, and patient setup. 
Although there is considerable development in IGRT 
technologies in Australia, little is known about their current 
clinical applications. The aim of this survey was to evaluate 
imaging technologies currently in use for planning and 
delivery of radiotherapy (RT) in Australia. 
